PEI

P.E.I. adds 10 new medications to drug program

Ten new drugs are being added to P.E.I.'s drug program later this month.

2nd time in 2015 drugs added to formulary by provincial government

Ten new drugs are being added to P.E.I.'s drug program later this month.

Health Minister Doug Currie said the new drugs will help over 200 patients with a variety of illnesses including cancer, gastrointestinal infection, and cystic fibrosis.

The drugs will also help people with attention deficit disorder, eye disorder and those wanting to quit smoking.

Currie said the provincial government will spend $1.4 million to add the drugs to the provincial plan. 

The new drugs added to the provincial formulary on Nov. 23 are: 

  • Cancer: Alimta (Mesothelioma), Alimta (lung cancer), Pomalyst, Revlimid, Vidaza
  • Cystic Fibrosis: HyperSal 7%
  • Gastrointestinal infection: Dificid
  • Attention-deficit hyperactivity disorder: Concerta/Biphentin
  • Vitreomacular adhesion (eye condition): Jetrea
  • Smoking cessation therapy: Champix

Patients have to meet clinical criteria and be registered with the provincial drug plan to be eligible for assistance. 

This is the second time in 2015 that new drugs have been added to the provincial formulary.

In April, 18 new medications were added to the plan and in September, a new Generic Drug Program was launched to provide coverage for uninsured Island residents under the age of 65. 

The Catastrophic Drug Program was introduced in 2013 to provide coverage for Islanders with high medication costs.

"Our government has been very proactive in adding drugs to the formulary, developing drug cost assistance programs, and expanding access to medications through new drug pricing initiatives," Currie said in a press release. 

Comments

To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.

Become a CBC Member

Join the conversation  Create account

Already have an account?

now